EE03421B1 - Progesteroonantagonistlike ja antiöstrogeensete omadustega ühendid kombineeritud kasutamiseks naiste kontratseptsioonil - Google Patents

Progesteroonantagonistlike ja antiöstrogeensete omadustega ühendid kombineeritud kasutamiseks naiste kontratseptsioonil

Info

Publication number
EE03421B1
EE03421B1 EE9700143A EE9700143A EE03421B1 EE 03421 B1 EE03421 B1 EE 03421B1 EE 9700143 A EE9700143 A EE 9700143A EE 9700143 A EE9700143 A EE 9700143A EE 03421 B1 EE03421 B1 EE 03421B1
Authority
EE
Estonia
Prior art keywords
compounds
combined use
female contraception
estrogenic properties
progesterone
Prior art date
Application number
EE9700143A
Other languages
English (en)
Estonian (et)
Other versions
EE9700143A (et
Inventor
Chwalisz Kristof
St�ckemann Klaus
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE9700143A publication Critical patent/EE9700143A/xx
Publication of EE03421B1 publication Critical patent/EE03421B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
EE9700143A 1994-12-23 1995-12-23 Progesteroonantagonistlike ja antiöstrogeensete omadustega ühendid kombineeritud kasutamiseks naiste kontratseptsioonil EE03421B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447402 1994-12-23
PCT/EP1995/005106 WO1996019997A1 (de) 1994-12-23 1995-12-23 Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption

Publications (2)

Publication Number Publication Date
EE9700143A EE9700143A (et) 1997-12-15
EE03421B1 true EE03421B1 (et) 2001-06-15

Family

ID=6537602

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700143A EE03421B1 (et) 1994-12-23 1995-12-23 Progesteroonantagonistlike ja antiöstrogeensete omadustega ühendid kombineeritud kasutamiseks naiste kontratseptsioonil

Country Status (24)

Country Link
US (1) US6362237B1 (lt)
EP (1) EP0799042A1 (lt)
JP (1) JPH10511378A (lt)
KR (1) KR100385663B1 (lt)
CN (1) CN1075375C (lt)
AU (1) AU710819B2 (lt)
BG (1) BG62384B1 (lt)
BR (1) BR9510550A (lt)
CA (1) CA2208321A1 (lt)
CZ (1) CZ288062B6 (lt)
EE (1) EE03421B1 (lt)
FI (1) FI972623A (lt)
HU (1) HUT77519A (lt)
IL (1) IL116505A0 (lt)
LT (1) LT4291B (lt)
LV (1) LV11883B (lt)
NO (1) NO314066B1 (lt)
NZ (1) NZ298769A (lt)
PL (1) PL183843B1 (lt)
RO (1) RO121086B1 (lt)
SI (1) SI9520136A (lt)
SK (1) SK284538B6 (lt)
WO (1) WO1996019997A1 (lt)
ZA (1) ZA9510926B (lt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652408C2 (de) * 1996-12-06 2002-04-18 Schering Ag Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP4382735B2 (ja) * 2005-10-06 2009-12-16 独立行政法人科学技術振興機構 神経因性疼痛治療剤
JP2011507853A (ja) * 2007-12-20 2011-03-10 テバ ウィメンズ ヘルス インコーポレイテッド 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824733C2 (de) 1978-06-06 1984-03-15 Heidelberger Druckmaschinen Ag, 6900 Heidelberg Umführtrommel für Schön- und Widerdruckmaschinen
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
ES533260A0 (es) 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
DE3322285A1 (de) 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
AU580843B2 (en) 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3533175A1 (de) 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE3708942A1 (de) 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
ES2045082T3 (es) 1987-04-24 1994-01-16 Akzo Nv Un metodo para la preparacion de nuevos derivados 11-arilestrano y 11-arilpregnano.
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
ATE85342T1 (de) 1987-12-12 1993-02-15 Akzo Nv 11-arylsteroid-derivate.
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE3926365A1 (de) 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
CH683151A5 (de) 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
MX9302312A (es) 1992-04-21 1994-06-30 Ligand Pharm Inc Compuestos agonistas y antagonistas receptores de la progesterona, no esteroides y composiciones farmaceuticas que los contienen.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein

Also Published As

Publication number Publication date
CZ195397A3 (en) 1997-11-12
CA2208321A1 (en) 1996-07-04
BR9510550A (pt) 1998-06-16
NO972877D0 (no) 1997-06-20
AU710819B2 (en) 1999-09-30
PL320786A1 (en) 1997-10-27
KR100385663B1 (ko) 2003-08-19
CN1171051A (zh) 1998-01-21
NO972877L (no) 1997-08-22
MX9704742A (es) 1997-10-31
RO121086B1 (ro) 2006-12-29
EE9700143A (et) 1997-12-15
HUT77519A (hu) 1998-05-28
NO314066B1 (no) 2003-01-27
IL116505A0 (en) 1996-03-31
JPH10511378A (ja) 1998-11-04
SK78997A3 (en) 1998-01-14
CN1075375C (zh) 2001-11-28
LT97107A (en) 1997-10-27
SK284538B6 (sk) 2005-06-02
CZ288062B6 (cs) 2001-04-11
WO1996019997A1 (de) 1996-07-04
SI9520136A (en) 1997-12-31
FI972623A0 (fi) 1997-06-18
KR980700866A (ko) 1998-04-30
AU4433796A (en) 1996-07-19
ZA9510926B (en) 1996-07-03
LT4291B (lt) 1998-02-25
LV11883A (lv) 1997-12-20
BG101553A (en) 1998-09-30
LV11883B (lv) 1998-05-20
NZ298769A (en) 2000-09-29
BG62384B1 (bg) 1999-10-29
PL183843B1 (pl) 2002-07-31
FI972623A (fi) 1997-06-18
EP0799042A1 (de) 1997-10-08
US6362237B1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
EE03421B1 (et) Progesteroonantagonistlike ja antiöstrogeensete omadustega ühendid kombineeritud kasutamiseks naiste kontratseptsioonil
BR9508107A (pt) Composição para uso em agricultura e agente de condicionamento
BR9502856A (pt) Dispositivo mostrador e peça para fabricação do mesmo
HUP0301417A2 (hu) Antimikrobális és fogamzásgátló készítmények és alkalmazásuk
ATE304359T1 (de) Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
BR9509651A (pt) Material superabsorvente e utilização do mesmo
BR9509650A (pt) Material superabsorvente e utilização do mesmo
BR9509264A (pt) Produto absorvente flexivel e estiravel para uso em uma peça íntima
HUP0300128A3 (en) Male contraceptive composition comprising norethisterone and its use
DE69507324D1 (de) Unterhose in einer grösse
BR9509261A (pt) Produto absorvente flexível para uso em uma peça íntima
KR950024498U (ko) 냉, 대하 및 월경 불순 치료용 파스
BR9509589A (pt) Artigo absorvente flexível para uso em uma peça íntima
HU9403092D0 (en) Medical device putable in the vagina
UA733S (uk) Внутріматковий протизаплідний засіб та пристрій для його введення
FIU960163U0 (fi) TV-kondomi ja TV-tamponipolariteetti ehkäisymenetelmätekniikka
KR950027227U (ko) 백밀러 빗물 차단장치와 보조 백밀러
FR2741536B1 (fr) Nouvelles compositions gynecologiques et leur utilisation en hygiene feminine
GB9403830D0 (en) Receptors and their use in assays
GB9823942D0 (en) Therapeutic antibody composition and use
GB9823931D0 (en) Therapeutic antibody composition and use
GB9823943D0 (en) Therapeutic antibody composition and use
GB9823939D0 (en) Therapeutic antibody composition and use
GB9823937D0 (en) Therapeutic antibody composition and use
GB9823936D0 (en) Therapeutic antibody composition and use

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081223